Floseal haemostatic matrix (Floseal VH S/D) - Procedural steps and scientific information after initial consultation

Human medicines European public assessment report (EPAR): Pregabalin Sandoz, pregabalin, Anxiety Disorders;Neuralgia;Epilepsy, Date of authorisation: 19/06/2015, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Angioedemas, Hereditary, Date of authorisation: 22/11/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Zynrelef, bupivacaine,meloxicam, Pain, Postoperative, Date of authorisation: 24/09/2020, Revision: 3, Status: Withdrawn

Human medicines European public assessment report (EPAR): Aqumeldi, Enalapril maleate, Heart Failure, Date of authorisation: 15/11/2023, Status: Authorised

Third Veterinary Big Data Stakeholder Forum, Amsterdam, from 23/11/2023 to 23/11/2023

CHMP opinions on consultation procedures

Opinion on medicine for use outside EU: Aluvia, lopinavir,ritonavir, HIV Infections, 21/09/2006 Positive opinion

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine,elasomeran,elasomeran / imelasomeran,elasomeran / davesomeran,andusomeran, COVID-19 virus infection, Date of authorisation: 06/01/2021, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Gavreto, pralsetinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 18/11/2021, Revision: 6, Status: Authorised